Clinical Research, Pharma & Healthcare FinancingVertex Announces CASGEVY® Reimbursement for SCD in EnglandBusiness WireJanuary 31, 2025August 1, 2025 by Business WireJanuary 31, 2025August 1, 20250129 – Agreement means eligible sickle cell disease (SCD) patients in England now have access to CASGEVY – – Agreement for CASGEVY in transfusion-dependent beta thalassemia...